Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV

Condition:   Human Immunodeficiency Virus Interventions:   Biological: M72/AS01E Mycobacterium tuberculosis vaccine;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials